Bayer Aktiengesellschaft (ETR:BAYN) Shares Up 0.7% – Here’s What Happened

Shares of Bayer Aktiengesellschaft (ETR:BAYN) traded up 0.7% on Wednesday. The company traded as high as €44.86 and last traded at €44.15. 1,860,703 shares were traded during trading, The stock had previously closed at €43.83.

Bayer Aktiengesellschaft Trading Up 0.7%

The company has a quick ratio of 0.72, a current ratio of 1.04 and a debt-to-equity ratio of 129.90. The business’s 50 day moving average is €48.05 and its 200-day moving average is €43.76. The firm has a market cap of $44.57 billion, a P/E ratio of -50.65, a price-to-earnings-growth ratio of 36.39 and a beta of 0.84.

Bayer Aktiengesellschaft Company Profile

Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy. The Consumer Health segment markets nonprescription over-the-counter medicines for self-medication and self-care; and solutions for nutritional supplements, allergy, cough and cold, dermatology, pain and cardiovascular risk prevention, and digestive health.